No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
300439 Medicalsystem Biotechnology
- 11.27
- +0.10+0.90%
Market Closed Dec 20 15:00 CST
4.33BMarket Cap17.23P/E (TTM)
11.32High11.08Low34.37KlotVolume11.15Open11.17Pre Close38.63MTurnover1.18%Turnover Ratio16.87P/E (Static)383.95MShares13.2452wk High1.50P/B3.29BFloat Cap7.1552wk Low13.40Limit Up291.73MShs Float77.92Historical High8.94Limit Down2.15%Amplitude7.15Historical Low0.13Dividend TTM11.24Avg Price16.80KlotAsk1.19%Div YieldTTM100Lot Size16.89KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Medicalsystem Biotechnology (300439.SZ) granted 0.4 million restricted stocks at a grant price of 6 yuan per share.
Medicalsystem Biotechnology (300439.SZ) announced that the company granted restricted Stocks to 11 incentive recipients for the year 2023...
Meikang Biotech: Report for the third quarter of 2024
medicalsystem biotechnology (300439.SZ) released its performance for the first three quarters, with a net income of 0.224 billion yuan, a year-on-year decrease of 2.43%.
Medicalsystem Biotechnology (300439.SZ) released the third quarter report for 2024, with a revenue of 14...
Meikang Biotech: 2024 Semi-Annual Report Summary
Meikang Biotech: 2024 Semi-Annual Report
Medicalsystem Biotechnology (300439.SZ) subsidiary terminates the cooperation on the Medical Linear Accelerator Radiotherapy Center project with Yinzhou Hospital.
Medicalsystem Biotechnology (300439.SZ) announced that its wholly-owned subsidiary, Ningbo Medicalsystem Shengda Biotechnology Co., Ltd. (abbreviated as...
